Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Fine by me. Just get the process done right and approved.
I could care less. All about the IDE.
They did not set an expectation--no guarantee.
Being "optimistic" isn't a commitment.
Sorry your feelings are hurt by them.
So this is your new pet focus now--on a tweet?
I thought it was "only about submitting IDE"?
Sounds like the Twitter flunky has eaten some lunch.
Emperor has no clothes.
Ooh--the scary 8!
Can't have it both ways:
Then: RDGL didn't listen to the FDA
Now: Why does the FDA want to meet and give us advice? It can only be bad news.
Then: So called "incompetence" by RDGL mgmt
Now: Walking hand in hand with the FDA and having mtgs is "poor" leadership. My porridge is cold.
Biased assumptions--not facts nor balanced assessment.
They dropped it on a Monday last time.
No--it went great. I was there.
Yes! We're all waiting.
Thanks, Capt. Obvious.
Exactly.
It's a hand in hand process with the FDA this time.
I'm not scared by meetings. I prefer a more balanced viewpoint that weighs both sides--not looking for every Boogieman to appear around every corner, which is a fear driven mentality.
This meeting may have several items on the agenda for all we know.
"This 4th meeting may have a favorable outcome, but unlikely given something complicated enough to require a meeting discussion has come up."
So you're predicting that due to this 4th meeting, RDGL will run into a delay with an unfavorable outcome?
Purpose and outcome of this meeting can easily be on the flip side and it's innocuous and meant for clarification as another commentator noted.
Nobody truly knows.
MK's statements always hold more sway than anyone here--for good or bad.
While not a great look for the stock in the short term, wouldn't mind a drop to buy more.
Don't think we're going below 5 today.
Au contraire, posts here do impact RDGL volume (trades or lack of trades). The negative opinions can surely sway potential and new investors. Simple psychology.
Interpret in the least favorable way you wish. Doesn't change the fact that IDE submission is imminent.
Try rereading the OP post and the post he replied to.
Doesn't explicitly or implicitly discuss whether RDGL will be used for certain cancers.
What he was referring to in this statement "I agree, possibilities are there in many forms." was what possibilities the April PR might cover--given the "iceberg" tweet about below water efforts.
Nothing to keep real here.
Train is continually moving to the next stop with massive momentum.
Another hurdle passed.
The past is irrelevant.
Cool story bro.
I've said the same before.
Guy acts as if he was in the room with MK, FDA, and Mayo.
Always speculation (e.g. Occam's razor) masquerading as fact.
They are one "pass go" on the containment study to submitting the IDE.
Your rationale is on another universe.
"Lack of progress"?
By that logic "all in the past" and it being "a distraction at the moment", sounds like the nonstop opinion on Korenko sitting on his hands, eating croissants, and swimming the Riviera the last two years is in the same category--dwelling in the past and a mere distraction.
Agreed.
It's like stating that all the Isopet work up till now hasn't benefitted the Radiogel project--clearly wrong opinion.
It's a nice find. Full stop.
No one here is pumping it beyond objectivity.
Me: It's sunny out today.
Someone: Yeah, but it wasn't yesterday.
Me: SMH.
The OTC CEO whisperer apparently
You're expecting tweets to move stock price?
Wow, stock investing not your game.
Try crypto, my friend.
In addition to "keeping it real" with "free shares" also "harems are tre chic"
Don't know the path? What's there else to know?
This isn't rocket science.
So simple, even a caveman understands. Well, most.
I'll take that as a no--no citations to present. Providing generalizations doesn't make the grade.
Bottom line: Predictions on submission is a futile sport. Only thing that matters is the trend line. At right now, it's trending proper.
One can't make such a claim without verifiable proof.
Postings #s? Didn't think so.
Your takes on this company are hilarious.
To avoid the polar extremes, proper context is uber important here:
- This is an OTC, not Fortune 1000
- Thus, budget is quite limited
- This is the med space, not software tech; therefore, dev cycles are not all microwave fast and in small batches
- Less than handful of full time staff: comprehensiveness is a tradeoff
- MK is not a marketer and hasn't ridden this med space rodeo before
To expect MK to strike perfection in his tenure is unmerited, and to not go through any learning curves (and timeline bumps) is unrealistic. On the contrary, to extend MK carte blanche, no objective feedback, crown him the unsung hero is misplaced.
RDGL headed in the right direction, with momentum, and prime milestones upcoming--assumed bumps included.
Why are we still discussing something from two years ago that is essentially irrelevant to the current state of affairs?
It’s not a long road. What’s two more years?
When swear words start flying, you know your stock is headed in the right direction.
Guesses on SP just after IDE approved?
If the barrier to entry was low to nonexistent, there would be more than one competitor.
Not every field of science is a simple bootstrap, out of the garage outfit. Takes plenty of resources, intelligence, organization, and persistence.
I'll let the pupils grade themselves -- said no teacher ever.